Foreign-born hispanics have survival advantage in NSCLC

August 22, 2013
Foreign-born hispanics have survival advantage in NSCLC
Compared with non-Hispanic whites and U.S.-born Hispanics, foreign-born Hispanics with non-small-cell lung cancer have a reduced risk of disease-specific mortality, according to research published online Aug. 19 in the Journal of Clinical Oncology.

(HealthDay)—Compared with non-Hispanic whites (NHWs) and U.S.-born Hispanics, foreign-born Hispanics with non-small-cell lung cancer (NSCLC) have a reduced risk of disease-specific mortality, according to research published online Aug. 19 in the Journal of Clinical Oncology.

Manali I. Patel, M.D., of Stanford University in California, and colleagues conducted a of data for 1998 to 2007 from the California Cancer Registry (with follow-up through 2009) for NHWs and 14,280 Hispanics with NSCLC to assess individual, clinical, and neighborhood factors in survival.

The researchers found a significantly lower risk of disease-specific mortality related to NSCLC in foreign-born Hispanics, compared with NHWs (hazard ratio [HR], 0.85) after adjustment for individual, clinical, and neighborhood factors, and compared with U.S.-born Hispanics (HR, 0.90) after adjustment for individual factors. Foreign-born Hispanics who lived in low socioeconomic and high Hispanic enclave neighborhoods had a compared with U.S.-born Hispanics.

"In conclusion, despite advanced stage at diagnosis, lower likelihood of treatment, and greater likelihood of living in low socioeconomic status neighborhoods, foreign-born Hispanics had improved survival after NSCLC than U.S.-born Hispanics and NHWs," the authors write.

Explore further: Hispanic lung cancer patients have higher survival than non-Hispanic white patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Hispanic lung cancer patients have higher survival than non-Hispanic white patients

September 6, 2012
Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry (CCR) database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival ...

Being born in another country may protect against stroke for US Hispanics

February 21, 2012
New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people. The research was released today and will be presented at the American ...

English-acculturated hispanics report less sun-safe behavior

April 18, 2013
(HealthDay)—English-acculturated and bicultural (high English and Spanish acculturation) Hispanic adults report lower engagement in skin cancer-related behaviors, according to a study published online April 17 in JAMA Dermatology.

Racial disparities in the surgical management of non-small cell lung cancer

May 21, 2013
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

Hispanic lung cancer patients tend to live longer than blacks and whites

April 23, 2012
A new analysis has found that Hispanic lung cancer patients seem to live longer than white or black patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that, ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.